In a commentary in The New York Times, Richard Ablin of the University of Arizona said the screening tool he discovered four decades ago now costs too much and is ineffective.
The American Cancer Society, which does not recommend the prostate specific antigen (PSA) test — a standard screening for men since the 1990s — has […]

continue reading from " PSA screening costs too much and is ineffective "

A new study at Yale School of Medicine, USA, aimed to quantitatively assess the effect of radical prostatectomy on the specific domains that comprise overall sexual function. Researchers focused on the relationships among these domains and overall sexual function in order to identify predictors for recovery of sexual function over time, as a decline in […]

continue reading from " Changes in specific domains of sexual function and sexual bother after radical prostatectomy "

Researchers at Van Andel Research Institute have developed a new method to better study the cells that line and protect the prostate in relation to the development of cancer. New model allows researchers to find that normal cells and cancer cells depend on different factors to survive. This factors help in discovering how to target cancer cells without affecting […]

continue reading from " New method to better study prostate cancer "

A recent research study has discovered, for the first time, a genetic mutation in African-American men with a family history of prostate cancer who are at increased risk for the disease. Scientific reports linking inheritable androgen receptor mutations to prostate cancer in Caucasians are rare, and this is the first one that focuses on the […]

continue reading from " Study has discovered a genetic mutation in African-American men with family history of prostate cancer "

A Myriad Genetics, Inc. (Nasdaq:MYGN) today release revealed that data providing further clinical validation supporting its newest molecular diagnostic product, PROLARIS, was recently presented at the 2010 Genitourinary Cancers Symposium in San Francisco.
The study at the Scott and White Clinic, Temple, Texas examined a well-described cohort of patients for which 10-year follow-up data were available […]

continue reading from " Study supports a molecular diagnostic test for predicting prostate cancer recurrence "

New preliminary information from a pilot study in the Netherlands indicates that imaging tools may help address the most challenging clinical dilemma of prostate cancer care.The preliminary study, at Radboud University, demonstrated a high discriminatory performance of the novel MRI methodology (Diffusion-Weighted Imaging) in separating aggressive prostate cancer that must be treated from harmless disease conditions […]

continue reading from " Imaging tools may help address challenging clinical dilemma of prostate cancer care "

New research at The Cancer Institute of New Jersey (CINJ) and Memorial Sloan-Kettering Cancer Center in New York, shows that the type of specialist that men with localized prostate cancer see can influence the form of therapy they ultimately receive. The study concluded that patients aged 65 and older who consult an urologist are more […]

continue reading from " Therapy prostate cancer patients receive is influenced by type of specialist that men see "

According to a study in the March issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of the American Society for Radiation Oncology (ASTRO), prostate-specific dietary supplements should not be taken during radiation therapy treatments. The study conclusions suggest that they have been shown to increase the radiosensitivity of normal prostate cell lines, […]

continue reading from " Dietary supplements discouraged for prostate cancer patients "

According to a new study from UT Southwestern Medical Center, a dutasteride-tamsulosin combination prescribed for enlarged prostate yielded better results than either of the medicines alone.
The study compared treatments for three groups of study participants with enlarged prostates over four years. Investigation including more than 4,800 men, is one of the first to compare single and […]

continue reading from " Dutasteride-tamsulosin combination therapy more effective in enlarged prostate "

According to Edward Partridge, M.D., president-elect of the American Cancer Society (ACS) National Board of Directors and director of the University of Alabama at Birmingham (UAB) Comprehensive Cancer Center, men who undergo prostate-cancer screening should discuss with a doctor the uncertainties, risks and benefits of the test before it is performed.
It is important for men […]

continue reading from " Men should discuss pros and cons with doctor before undergoing prostate-cancer screening "